AgIdea and Elemental Enzymes Sign Three-Year Agreement for Early-Stage Product Development in the U.S.
September 17, 2024 AgIdea and Elemental Enzymes have announced a new three-year agreement to advance screening of Elemental Enzymes’ cutting-edge technologies in the United States, focusing on row crops. This partnership, building on nearly a decade of successful collaboration, marks a significant milestone for both companies.
Brian Thompson, CEO of Elemental Enzymes, expressed his enthusiasm: “We’re excited to leverage AgIdea’s expertise during this crucial stage of our business development. This agreement highlights the value of such collaborations in bringing our innovative solutions to market.”
Gonzalo Grigera, CEO of AgIdea, added, “The innovative capabilities of Elemental Enzymes are truly remarkable. This long-term commitment is a rare achievement in our industry and reflects the deep trust and successful joint ventures we’ve developed over the years in the U.S., Argentina, and Brazil.”
Bret Gygi, Director of Technical Development at Elemental Enzymes, also commented: “The level of collaboration in this agreement is a first for me in 15+ years of working directly and indirectly with CROs. Elemental Enzymes will have direct input into the management practices at the trial sites.
“This brings with it the potential to have locations with specific fertility backgrounds tailored to better understand the limits and contributions our technologies have on crop performance.”
This strategic agreement enhances the strong relationship between AgIdea and Elemental Enzymes, positioning both companies at the forefront of innovation in the agro-industrial sector.
Subscribe Today For
